文献速递妇科

晚期上皮性卵巢癌实施超根治性手术后生存改善:来自三级转诊中心的结果

Improved survival after implementation of ultra-radical surgery in advanced epithelial ovarian cancer: Results from a tertiary referral center.
PubMed 文献 · Gynecol Oncol · 2022-04-06

芬兰坦佩雷大学医院2013-2019年247例FIGO IIIB-IV期卵巢、输卵管及原发腹膜癌患者,比较手术方式从标准手术系统转向超根治性手术前后(1组122例 vs 2组125例)的生存。完全切除率从17.2%升至52.0%,中位无进展生存15.6 vs 19.3个月,中位总生存33.5 vs 54.5个月。

要点

  • 完全切除率从17.2%(21/122)升至52.0%(65/125),p<0.001。
  • 中位无进展生存1组15.6个月 vs 2组19.3个月(p=0.037)。
  • 中位总生存1组33.5个月 vs 2组54.5个月(p=0.028)。

核心结论

  • 手术方式转向最大程度手术努力改善了无进展生存和总生存,III期患者生存获益明确,IV期患者未达统计学显著。

研究设计与样本

  • 芬兰坦佩雷大学医院2013-2019年247例FIGO IIIB-IV期卵巢、输卵管及原发腹膜癌患者,接受初次或中间型减瘤术。
  • 1组122例于2013年至2016年2月手术,2组125例于2016年3月至2019年3月手术,期间系统转向更广泛手术。

主要发现

  • 完全切除(R0)率从1组17.2%(21/122)升至2组52.0%(65/125),p<0.001。
  • 中位无进展生存1组15.6个月 vs 2组19.3个月(p=0.037)。
  • 中位总生存1组33.5个月 vs 2组54.5个月(p=0.028)。
  • III期患者中位总生存1组36.1个月(95%CI 27.4-44.8),2组未达到(p=0.009)。
  • IV期患者总生存1组32.0个月(95%CI 16.4-47.7)vs 2组39.3个月(95%CI 24.8-53.8)(p=0.691)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare survival rates of surgically treated advanced epithelial ovarian cancer patients before and after a programmatic change in surgical approach from standard surgery towards ultra-radical surgery. METHODS: 247 patients with FIGO stage IIIB-IV ovarian, tubal, and primary peritoneal carcinoma were operated during 2013-2019 either by primary or interval cytoreduction in Tampere University Hospital, Finland. Group 1 (n = 122) patients were operated during 2013 and February 2016. Group 2 patients (n = 125) were operated between March 2016 and March 2019, when a systematic change in surgical approach towards more extensive surgery was implemented. RESULTS: The complete resection (R0) rate increased significantly from 17.2% (21/122) to 52.0% (65/125) within the study period (p < 0.001). The median progression-free survival (PFS) was 15.6 months vs 19.3 months (p = 0.037), and the median overall survival (OS) was 33.5 months vs 54.5 months in Groups 1 and 2, respectively (p = 0.028). Median OS for stage III patients in Group 1 was 36.1 months (95% CI 27.4-44.8) but could not be reached in Group 2 (p = 0.009). In Stage IV patients, OS was 32.0 months (16.4-47.7) and 39.3 months (24.8-53.8) in Group 1 and 2, respectively (p = 0.691). Multivariable Cox regression analysis revealed that OS was independently affected by the amount of residual tumor and complication grade. CONCLUSIONS: The change of surgical approach towards maximal surgical effort improved both progression-free and overall survival. The survival benefit was unquestionable for stage III patients but did not reach statistical significance in stage IV patients.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Norppa N, Staff S, Helminen M, et al. Improved survival after implementation of ultra-radical surgery in advanced epithelial ovarian cancer: Results from a tertiary referral center. Gynecol Oncol. 2022. PMID: 35397919. doi:10.1016/j.ygyno.2022.03.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。